EchoCRT Non-response Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Patient characteristics

Enter the clinical, ECG, and echocardiographic variables below. This calculator reproduces the heuristic scoring rules in the supplied source file.

—Score

The source score assigns 1 point for age >70 years.

Male sex contributes 1 point in the source score.

Absence of LBBB contributes 2 points in the source score.

The source score assigns 2 points for QRS <150 ms.

The source score assigns 1 point for LVESVI >90 mL/m².

The source score assigns 1 point for LVEF <25%.

Important clinical limitation: The supplied code describes these weights as an approximation, and the cited publication could not be verified as the source of this exact 7-variable score or its 20%/45%/70% probability bands. Treat this output as an educational prototype only—not as a validated EchoCRT risk model or a basis for CRT eligibility or treatment decisions.

Score components in the supplied code

This page preserves the source file's additive points and thresholds while making their unvalidated status explicit.

VariableCriterionPoints
Age>70 years+1
SexMale+1
EtiologyIschemic cardiomyopathy+2
QRS morphologyLBBB absent+2
QRS duration<150 ms+2
LVESVI>90 mL/m²+1
LVEF<25%+1

Source-code categories (unvalidated)

Total scoreSource labelSource estimate
0–2Low~20%
3–5Intermediate~45%
6–10High~70%

Evidence and clinical context

CRT response is multifactorial. Ischemic etiology, QRS morphology and duration, myocardial scar, mechanical activation, LV geometry, lead position, and effective biventricular pacing can all influence outcomes. These associations do not validate the particular score implemented here.

The EchoCRT trial studied patients with heart failure and narrow QRS duration (<130 ms) despite echocardiographic dyssynchrony; its findings should not be presented as proof that CRT benefits this population.

References checked

Ruschitzka F, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.N Engl J Med. 2013;369:1395–1405. DOI: 10.1056/NEJMoa1306687. EchoCRT trial.
Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy.American Heart Journal. 2011;161(3):552–557. DOI: 10.1016/j.ahj.2010.11.011. This study identified several associations, but does not establish the exact score and probability bands above.
Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.Open-access article: PubMed Central.
Clinical disclaimer: This educational calculator has not been established as a validated prediction model. Do not use its score or approximate percentages to select or exclude patients from CRT. Apply current guideline-based eligibility criteria, clinical assessment, and shared decision-making. The clinical evidence and the original citation for the specific scoring system require confirmation before production use.